Biotech Values : BHVN intranasal migraine drug bests plac...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Biotech Values

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	843
Posts	122807
Boards Moderated	10
Alias Born	09/05/2002

Re: DewDiligence post# 240287

Monday, 12/06/2021 11:59:13 AM

Monday, December 06, 2021 11:59:13 AM

BHVN intranasal migraine drug bests placebo in second phase-3 trial—NDA expected in 1Q22:

https://www.prnewswire.com/news-releases/biohaven-reports-positive-topline-results-from-pivotal-migraine-trial-of-intranasal-zavegepant-demonstrating-ultra-rapid-pain-relief-by-15-minutes-prepares-for-submission-of-new-drug-application-301437767.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow